Friday, October 04, 2019

[ASAP] Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment

TOC Graphic

Nano Letters
DOI: 10.1021/acs.nanolett.9b03214


from Nano Letters: Latest Articles (ACS Publications) https://ift.tt/31MKPyP
via IFTTT

No comments:

Post a Comment